Akero Therapeutics, Inc

(NASDAQ:AKRO)

Latest On Akero Therapeutics, Inc (AKRO):

Date/Time Type Description Signal Details
2023-05-18 02:59 ESTNewsAkero Therapeutics: A Promising Solution For NASH Patients And InvestorsN/A
2023-05-17 13:48 ESTNewsAkero Therapeutics prices $220M offeringN/A
2023-05-15 20:39 ESTNewsAkero Therapeutics GAAP EPS of -$0.55N/A
2023-05-09 09:17 ESTNewsAkero Therapeutics: Proof Of Concept With EFX, Sets Up Catalyst Opportunities In 2023N/A
2023-05-07 19:00 ESTNewsAkero Therapeutics: Excellent Data, Solid Clinical Potential, No Major Near Term CatalystsN/A
2023-03-30 00:33 ESTNewsAkero plans to begin Phase 3 trial of NASH treatment in H2 after successful FDA meetN/A
2023-03-17 20:34 ESTNewsAkero Therapeutics GAAP EPS of -$0.49 beats by $0.31N/A
2023-02-08 18:19 ESTNewsAkero Therapeutics: NASH Differentiator Attractive, Awaiting Additional Price CatalystsN/A
2023-01-27 18:31 ESTNewsAkero upgraded at Morgan Stanley on NASH prospectsN/A
2022-12-08 21:25 ESTNewsAkero's liver disease drug gets FDA breakthrough therapy tagN/A
2022-11-24 02:08 ESTNewsAkero Therapeutics: What Is Making The Stock TickN/A
2022-11-04 15:25 ESTNewsAkero Therapeutics GAAP EPS of -$0.92 misses by $0.20N/A
2022-10-25 22:18 ESTNewsAkero: Putting Together The Pieces They Let Us SeeN/A
2022-09-19 18:37 ESTNewsAkero Therapeutics announces closing of upsized public offeringN/A
2022-09-19 02:04 ESTNewsAkero Therapeutics: A Promising NASH InnovatorN/A
2022-09-16 05:21 ESTNewsAkero Therapeutics: Outstanding Data In NASHN/A
2022-09-15 11:26 ESTNewsAkero Therapeutics stock slides on pricing upsized ~$200.0M stock offeringN/A
2022-09-14 18:07 ESTNewsAkero Therapeutics' Positive NASH Trial Results And Cash RaiseN/A
2022-09-14 00:37 ESTNewsAkero stock soars 71% as drug improves liver fibrosis, prevents disease worsening in trialN/A
2022-09-14 00:36 ESTNewsAkero adds over 100% rallying peers after NASH successN/A
2022-09-14 00:36 ESTNewsAkero Therapeutics commences underwritten public offering of $175M of sharesN/A
2022-08-04 23:03 ESTNewsAkero Therapeutics GAAP EPS of -$0.77 beats by $0.10N/A
2022-06-16 14:38 ESTNewsPfizer makes $25M equity investment in AkeroN/A
2022-05-06 18:49 ESTNewsAkero Therapeutics GAAP EPS of -$0.74 beats by $0.07N/A
2022-02-25 22:21 ESTNewsAkero Therapeutics GAAP EPS of -$0.93 misses by $0.13N/A
2022-02-09 07:08 ESTNewsAkero finishes enrollment in phase 2b trial of efruxifermin in liver diseaseN/A
2022-01-12 18:10 ESTNewsAkero Therapeutics (AKRO) Presents At 40th Annual J.P. Morgan Virtual Healthcare ConferenceN/A
2022-01-12 18:10 ESTNewsAkero Therapeutics (AKRO) Investor Presentation - SlideshowN/A
2021-11-12 16:26 ESTNewsAkero Therapeutics EPS beats by $0.16N/A
2021-10-20 02:11 ESTNewsAkero nabs Fast Track designation for efruxifermin for NASHN/A
2021-10-12 20:08 ESTNewsWarning: AKRO is at high risk of performing badlyN/A
2021-10-07 04:15 ESTNewsAKRO is at high risk of performing badlyN/A
2021-09-27 12:22 ESTNewsWarning: AKRO has been downgraded to Very BearishN/A
2021-09-23 22:19 ESTNewsAkero: Ticking All The Right Boxes In NASHN/A
2021-09-22 20:56 ESTNewsWarning: AKRO has been downgraded to Very Bearish.N/A
2021-09-10 16:11 ESTNewsAkero initiated with a buy at BofA on underappreciated clinical profileN/A
2021-08-13 08:25 ESTNewsAkero Therapeutics EPS misses by $0.17N/A
2021-07-20 18:14 ESTNewsAkero Therapeutics' efruxifermin meets primary endpoint in mid-stage NASH trialN/A
2021-07-20 18:08 ESTNewsAkero Therapeutics adds Judy Chou to its board of directorsN/A
2021-04-21 13:38 ESTNews89bio could close the valuation gap with Akero by end of 2021: CantorN/A
2021-03-18 12:04 ESTAnalyst RatingThe Analyst Target Price has decreased from $59.5 to $58.75.Neutral
2021-03-17 20:05 ESTFinancialsCompany financials have been released.Neutral
2021-03-17 12:03 ESTEarnings EstimateAn EPS average of -$3.73 is estimated for the 2022 year.Sell
2021-03-17 12:03 ESTEarnings EstimateAn EPS average of -$0.80 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-16 18:57 ESTNewsAkero Therapeutics EPS misses by $0.29N/A
2021-03-01 11:04 ESTAnalyst RatingThe Analyst Target Price has decreased from $60.29 to $59.5.Neutral
2020-12-13 03:07 ESTFinancialsCompany financials have been released.Neutral
2020-12-11 15:05 ESTFinancialsCompany financials have been released.Neutral
2020-11-25 11:09 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 03:04 ESTFinancialsCompany financials have been released.Neutral

About Akero Therapeutics, Inc (AKRO):

Akero Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for serious metabolic diseases. Its lead product candidate is AKR-001, which is in Phase IIa clinical trial for the treatment of nonalcoholic steatohepatitis disease.The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was founded in 2017 and is headquartered in South San Francisco, California.

See Advanced Chart

General

  • Name Akero Therapeutics, Inc
  • Symbol AKRO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 13
  • Fiscal Year EndDecember
  • IPO Date2019-06-20
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.akerotx.com
View More

Valuation

  • Trailing PE 8.18
  • Price/Book (Most Recent Quarter) 4.38
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$3.88
  • Next Year EPS Estimate -$4.26
  • Next Quarter EPS Estimate -$0.55
  • Return on Assets -18%
  • Return on Equity -30%
  • Earnings Per Share -$91.75
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 1.11 billion
  • Analyst Target Price $58.75
  • Book Value Per Share $8.25
View More

Share Statistics

  • Shares Outstanding 34.77 million
  • Shares Float 17.06 million
  • % Held by Insiders 840%
  • % Held by Institutions 93.8%
  • Shares Short 2.23 million
  • Shares Short Prior Month 2.13 million
  • Short Ratio 9.66
  • Short % of Float 12%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • 52 Week High $41.16
  • 52 Week Low $15.02
  • 50 Day Moving Average 31.18
  • 200 Day Moving Average 29.64
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Akero Therapeutics, Inc (AKRO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Akero Therapeutics, Inc (AKRO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-16$N/A-$0.86-$0.59-45.76%
2020-09-302020-11-12$N/A-$0.63-$0.676.11%
2020-06-302020-08-12$N/A-$0.57-$0.627.72%
2020-03-312020-05-13$N/A-$0.42-$0.6131.15%
2019-12-312020-03-16$N/A-$0.55-$0.585.97%
2019-09-302019-11-12$N/A-$0.56-$0.43-30.69%
2019-06-302019-08-12$N/A-$0.26-$0.3628.51%

Akero Therapeutics, Inc (AKRO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Akero Therapeutics, Inc (AKRO) Chart:

Akero Therapeutics, Inc (AKRO) News:

Below you will find a list of latest news for Akero Therapeutics, Inc (AKRO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Akero Therapeutics, Inc (AKRO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-11-21200CALL0 0245.55TRUE00
2025-11-2122.50CALL0 0218.32TRUE00
2025-11-212528.83CALL0 0194.1TRUE00
2025-11-2127.50CALL0 0172.26TRUE00
2025-11-213023.9CALL0 1157.51TRUE00
2025-11-2132.50CALL0 0138.73TRUE00
2025-11-21350CALL0 0132.45TRUE00
2025-11-2137.510.1CALL0 185.96TRUE00
2025-11-21407.3CALL0 4098.61TRUE00
2025-11-2142.59.3CALL0 1082.89TRUE00
2025-11-21459.3CALL0 3780TRUE00
2025-11-2147.56.9CALL0 1750TRUE00
2025-11-21504.3CALL0 29428.94TRUE00
2025-11-2152.51.08CALL0 887.25TRUE00
2025-11-21550.05CALL75 17455.09FALSE0.050
2025-11-2157.50.05CALL0 537715.45FALSE00
2025-11-21600.05CALL0 36332.75FALSE00
2025-11-2162.50.05CALL0 7296.87FALSE00
2025-11-21650.05CALL0 89109.25FALSE00
2025-11-21700.4CALL0 1629131.07FALSE00
2025-11-21751.05CALL0 13663.44FALSE00
2025-11-21800.45CALL0 4773.93FALSE00
2025-11-21200PUT0 0184.89FALSE00
2025-11-2122.50PUT0 0164.42FALSE00
2025-11-21250PUT0 0146.12FALSE00
2025-11-2127.50PUT0 0129.56FALSE00
2025-11-21300.5PUT0 8114.4FALSE00
2025-11-2132.50.7PUT0 30100.39FALSE00
2025-11-21350.05PUT0 4187.33FALSE00
2025-11-2137.50.05PUT0 11275.07FALSE00
2025-11-21400.05PUT0 75163.47FALSE00
2025-11-2142.53.3PUT0 4552.41FALSE00
2025-11-21450.05PUT0 45654.8FALSE00
2025-11-2147.50.45PUT0 82101.62FALSE00
2025-11-21500.1PUT0 39021.11FALSE00
2025-11-2152.50.05PUT0 9910.49FALSE00
2025-11-21550.8PUT6 75.32TRUE0.80
2025-11-2157.53.65PUT0 024.43TRUE00
2025-11-21608.4PUT0 047.89TRUE00
2025-11-2162.510.8PUT0 00TRUE00
2025-11-216513.4PUT0 1074.48TRUE00
2025-11-21700PUT0 083.98TRUE00
2025-11-21750PUT0 099.73TRUE00
2025-11-21800PUT0 0105.89TRUE00
2025-12-1932.50CALL0 00TRUE00
2025-12-19350CALL0 00TRUE00
2025-12-1937.50CALL0 00TRUE00
2025-12-19400CALL0 00TRUE00
2025-12-1942.50CALL0 00TRUE00
2025-12-19450CALL0 00TRUE00
2025-12-1947.50CALL0 00TRUE00
2025-12-19500CALL0 00TRUE00
2025-12-1952.50.45CALL0 119.19TRUE00
2025-12-19550.1CALL20 103.6FALSE-0.1-0.5
2025-12-1957.50CALL0 042.75FALSE00
2025-12-19600CALL0 052.94FALSE00
2025-12-1962.50CALL0 061.87FALSE00
2025-12-19650CALL0 069.89FALSE00
2025-12-19700CALL0 084.03FALSE00
2025-12-19750CALL0 096.29FALSE00
2025-12-19800CALL0 0107.17FALSE00
2025-12-1932.50PUT0 0152.92FALSE00
2025-12-19350PUT0 0136.61FALSE00
2025-12-1937.50PUT0 0121.3FALSE00
2025-12-19400PUT0 0106.81FALSE00
2025-12-1942.50PUT0 092.93FALSE00
2025-12-19450PUT0 079.5FALSE00
2025-12-1947.50PUT0 066.3FALSE00
2025-12-19500PUT0 053.07FALSE00
2025-12-1952.50PUT0 012.77FALSE00
2025-12-19550PUT0 035.76TRUE00
2025-12-1957.50PUT0 00TRUE00
2025-12-19600PUT0 00TRUE00
2025-12-1962.50PUT0 00TRUE00
2025-12-19650PUT0 00TRUE00
2025-12-19700PUT0 00TRUE00
2025-12-19750PUT0 00TRUE00
2025-12-19800PUT0 00TRUE00
2026-01-162.50CALL0 0315.89TRUE00
2026-01-1650CALL0 0228.62TRUE00
2026-01-167.50CALL0 0177.94TRUE00
2026-01-16100CALL0 0137.78TRUE00
2026-01-1612.50CALL0 20TRUE00
2026-01-16150CALL0 00TRUE00
2026-01-1617.536.55CALL0 380TRUE00
2026-01-162032CALL0 80TRUE00
2026-01-1622.50CALL0 100TRUE00
2026-01-162525CALL0 210TRUE00
2026-01-1627.521.85CALL0 110TRUE00
2026-01-163023.95CALL0 1220TRUE00
2026-01-1632.50CALL0 1559.77TRUE00
2026-01-163518.9CALL0 1454.23TRUE00
2026-01-1637.517.05CALL0 3045.68TRUE00
2026-01-164013.8CALL0 5537.7TRUE00
2026-01-1642.511.42CALL0 6032.86TRUE00
2026-01-16459.56CALL0 4025.71TRUE00
2026-01-1647.56.3CALL0 48220.75TRUE00
2026-01-16504.5CALL0 132624.14TRUE00
2026-01-1652.52.23CALL0 7712.85TRUE00
2026-01-16550.05CALL1 5951.67FALSE0.050
2026-01-1657.50.08CALL1 988.08FALSE0.080
2026-01-16600.05CALL0 14234.2FALSE00
2026-01-1662.50.05CALL0 777.1FALSE00
2026-01-16651.24CALL0 13084.17FALSE00
2026-01-16700.1CALL0 37545.03FALSE00
2026-01-16750.05CALL0 25732.01FALSE00
2026-01-16800.15CALL0 50037.4FALSE00
2026-01-16851.02CALL0 442.35FALSE00
2026-01-162.50PUT0 00FALSE00
2026-01-1650PUT0 15247.24FALSE00
2026-01-167.50PUT0 0625.32FALSE00
2026-01-16100PUT0 0495.06FALSE00
2026-01-1612.50PUT0 15417.53FALSE00
2026-01-16150PUT0 0362.68FALSE00
2026-01-1617.50PUT0 2320.39FALSE00
2026-01-16200.05PUT0 16995.38FALSE00
2026-01-1622.50PUT0 1257.09FALSE00
2026-01-16250.45PUT0 5775.49FALSE00
2026-01-1627.50.7PUT0 2209.96FALSE00
2026-01-16300.05PUT0 4765.54FALSE00
2026-01-1632.51.65PUT0 557.71FALSE00
2026-01-16350.05PUT0 34155.5FALSE00
2026-01-1637.50.05PUT0 3140.04FALSE00
2026-01-16400.1PUT0 472744.36FALSE00
2026-01-1642.54.1PUT0 39111.69FALSE00
2026-01-16455.7PUT0 1828.8FALSE00
2026-01-1647.50.3PUT0 4322.32FALSE00
2026-01-16500.4PUT0 113715.27FALSE00
2026-01-1652.50.7PUT0 30110.59FALSE00
2026-01-16551.35PUT0 62812.01TRUE00
2026-01-1657.53.9PUT0 217.26TRUE00
2026-01-16606.1PUT0 123.59TRUE00
2026-01-1662.50PUT0 029.46TRUE00
2026-01-16650PUT0 034.8TRUE00
2026-01-16700PUT0 248.43TRUE00
2026-01-16750PUT0 057.25TRUE00
2026-01-168025.2PUT0 065.18TRUE00
2026-01-16850PUT0 062.54TRUE00
2026-02-2022.50CALL0 00TRUE00
2026-02-20250CALL0 00TRUE00
2026-02-2027.50CALL0 00TRUE00
2026-02-20300CALL0 048.39TRUE00
2026-02-2032.50CALL0 037TRUE00
2026-02-20350CALL0 00TRUE00
2026-02-2037.50CALL0 024.55TRUE00
2026-02-20409CALL0 40TRUE00
2026-02-2042.512CALL0 360TRUE00
2026-02-20456.1CALL0 415.59TRUE00
2026-02-2047.57CALL0 10TRUE00
2026-02-20504.31CALL0 818.94TRUE00
2026-02-2052.51.9CALL0 69.05TRUE00
2026-02-20550.3CALL0 3882.24FALSE00
2026-02-2057.50.05CALL0 178.3FALSE00
2026-02-20600.05CALL0 3727.81FALSE00
2026-02-2062.50CALL0 063.27FALSE00
2026-02-20651.05CALL0 1362.16FALSE00
2026-02-20700.05CALL0 1379.52FALSE00
2026-02-20750CALL0 088.51FALSE00
2026-02-20800.35CALL0 1638.19FALSE00
2026-02-2022.50PUT0 070.47FALSE00
2026-02-20250.95PUT0 469.17FALSE00
2026-02-2027.51.25PUT0 4174.31FALSE00
2026-02-20301.5PUT0 3157.9FALSE00
2026-02-2032.50PUT0 0142.97FALSE00
2026-02-20351.85PUT0 2129.22FALSE00
2026-02-2037.50PUT0 0116.43FALSE00
2026-02-20404.2PUT0 2104.41FALSE00
2026-02-2042.54.8PUT0 592.99FALSE00
2026-02-20451.4PUT0 956.37FALSE00
2026-02-2047.50.35PUT0 88218.18FALSE00
2026-02-20502.1PUT0 634.42FALSE00
2026-02-2052.50.25PUT18 9118.52FALSE0.250
2026-02-20551.3PUT0 13108.76TRUE00
2026-02-2057.53.9PUT0 1315.13TRUE00
2026-02-20600PUT0 020.59TRUE00
2026-02-2062.50PUT0 025.62TRUE00
2026-02-20650PUT0 030.19TRUE00
2026-02-20700PUT0 042.42TRUE00
2026-02-20750PUT0 049.99TRUE00
2026-02-20800PUT0 055.94TRUE00
2026-05-15250CALL0 00TRUE00
2026-05-1527.50CALL0 00TRUE00
2026-05-15300CALL0 00TRUE00
2026-05-1532.50CALL0 00TRUE00
2026-05-15350CALL0 00TRUE00
2026-05-1537.50CALL0 00TRUE00
2026-05-15400CALL0 00TRUE00
2026-05-1542.510.65CALL0 00TRUE00
2026-05-15450CALL0 00TRUE00
2026-05-1547.59.39CALL0 10TRUE00
2026-05-15505CALL0 50TRUE00
2026-05-1552.50CALL0 00TRUE00
2026-05-15550.35CALL1 3751.03FALSE0.350
2026-05-1557.50.3CALL0 419.96FALSE00
2026-05-15600.15CALL0 912.28FALSE00
2026-05-1562.50CALL0 029.14FALSE00
2026-05-15650CALL0 033.21FALSE00
2026-05-15701CALL0 140.34FALSE00
2026-05-15250PUT0 058.97FALSE00
2026-05-1527.50PUT0 095.52FALSE00
2026-05-15300.25PUT0 546.76FALSE00
2026-05-1532.50PUT0 077.32FALSE00
2026-05-15350.15PUT0 069.23FALSE00
2026-05-1537.50PUT0 061.64FALSE00
2026-05-15400PUT0 054.47FALSE00
2026-05-1542.50PUT0 030.12FALSE00
2026-05-15450.05PUT0 625.12FALSE00
2026-05-1547.50.6PUT0 1034.89FALSE00
2026-05-15500.7PUT0 1118.92FALSE00
2026-05-1552.50.25PUT1 667.05FALSE0.250
2026-05-15551.25PUT39 15347.72TRUE1.250
2026-05-1557.54PUT0 3211.14TRUE00
2026-05-15606.2PUT0 6124.87TRUE00
2026-05-1562.58.7PUT0 119.44TRUE00
2026-05-15650PUT0 022.96TRUE00
2026-05-15700PUT0 032.14TRUE00
2027-01-1522.50CALL0 00TRUE00
2027-01-15250CALL0 00TRUE00
2027-01-1527.50CALL0 00TRUE00
2027-01-15300CALL0 00TRUE00
2027-01-1532.50CALL0 00TRUE00
2027-01-15350CALL0 00TRUE00
2027-01-1537.50CALL0 00TRUE00
2027-01-154015.72CALL0 10TRUE00
2027-01-1542.50CALL0 00TRUE00
2027-01-15458.5CALL0 10TRUE00
2027-01-1547.50CALL0 00TRUE00
2027-01-15500CALL0 00TRUE00
2027-01-1552.53.5CALL0 200TRUE00
2027-01-15550.94CALL0 47.97FALSE00
2027-01-1557.50CALL0 022.73FALSE00
2027-01-15600.05CALL0 57.79FALSE00
2027-01-1562.50CALL0 030.16FALSE00
2027-01-15655.95CALL0 133.26FALSE00
2027-01-15700CALL0 038.68FALSE00
2027-01-1522.50.15PUT0 1040.17FALSE00
2027-01-15250PUT0 040.21FALSE00
2027-01-1527.50PUT0 091.92FALSE00
2027-01-15300.17PUT0 083.49FALSE00
2027-01-1532.50PUT0 075.85FALSE00
2027-01-15355PUT0 168.83FALSE00
2027-01-1537.50PUT0 028.85FALSE00
2027-01-15400PUT0 025.74FALSE00
2027-01-1542.50.05PUT0 823.13FALSE00
2027-01-15450PUT0 021.18FALSE00
2027-01-1547.50PUT0 039.46FALSE00
2027-01-15500.25PUT0 6110.71FALSE00
2027-01-1552.50.3PUT250 396.11FALSE0.30
2027-01-15551.6PUT0 508.3TRUE00
2027-01-1557.53.7PUT0 1015.9TRUE00
2027-01-15606.2PUT0 1213.22TRUE00
2027-01-1562.50PUT0 016.23TRUE00
2027-01-15650PUT0 018.95TRUE00
2027-01-15700PUT0 023.8TRUE00
2028-01-2122.531.6CALL0 00TRUE00
2028-01-21250CALL0 00TRUE00
2028-01-2127.50CALL0 00TRUE00
2028-01-21300CALL0 00TRUE00
2028-01-2132.50CALL0 00TRUE00
2028-01-21350CALL0 00TRUE00
2028-01-2137.519CALL0 10TRUE00
2028-01-21400CALL0 00TRUE00
2028-01-2142.50CALL0 00TRUE00
2028-01-21450CALL0 00TRUE00
2028-01-2147.50CALL0 00TRUE00
2028-01-21500CALL0 00TRUE00
2028-01-2152.55.3CALL0 110TRUE00
2028-01-21551.05CALL2 5630FALSE0.050.05
2028-01-2157.50CALL0 00FALSE00
2028-01-21600CALL0 017.34FALSE00
2028-01-2162.50CALL0 020.09FALSE00
2028-01-21650CALL0 022.52FALSE00
2028-01-21700.25CALL0 18.35FALSE00
2028-01-2122.50PUT0 084.72FALSE00
2028-01-21250PUT0 076.78FALSE00
2028-01-2127.50PUT0 069.79FALSE00
2028-01-21300PUT0 063.55FALSE00
2028-01-2132.50PUT0 057.89FALSE00
2028-01-21350PUT0 052.69FALSE00
2028-01-2137.50.05PUT0 647.87FALSE00
2028-01-21400PUT0 019.38FALSE00
2028-01-2142.50.2PUT0 1039.08FALSE00
2028-01-21450PUT0 015.11FALSE00
2028-01-2147.50PUT0 014.3FALSE00
2028-01-21500.92PUT0 710.17FALSE00
2028-01-2152.50.55PUT0 2177.07FALSE00
2028-01-21553.03PUT0 97.96TRUE00
2028-01-2157.54.1PUT0 10014.07TRUE00
2028-01-21600PUT0 011.82TRUE00
2028-01-2162.50PUT0 014.35TRUE00
2028-01-21650PUT0 016.62TRUE00
2028-01-21700PUT0 020.63TRUE00

Latest AKRO Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST22$8.07
Jun 13, 2022 7:59 PM EST11$8.07
Jun 13, 2022 7:59 PM EST14$8.06
Jun 13, 2022 7:59 PM EST10$8.07
Jun 13, 2022 7:59 PM EST47$8.07

Akero Therapeutics, Inc (AKRO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1744659/000110465920079692/0001104659-20-079692-index.htm
2020-05-20UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1744659/000000000020004520/0000000000-20-004520-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000090514820000773/0000905148-20-000773-index.htm
2020-07-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1744659/000090514820000781/0000905148-20-000781-index.htm
2020-09-09SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1744659/000090514820001009/0000905148-20-001009-index.htm
2020-05-15DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1744659/000091205720000169/0000912057-20-000169-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000013/0001012975-20-000013-index.htm
2020-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000022/0001012975-20-000022-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000029/0001012975-20-000029-index.htm
2020-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000033/0001012975-20-000033-index.htm
2020-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000113/0001012975-20-000113-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000115/0001012975-20-000115-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000119/0001012975-20-000119-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000267/0001012975-20-000267-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000275/0001012975-20-000275-index.htm
2020-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000101297520000291/0001012975-20-000291-index.htm
2020-07-06S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1744659/000104746920003964/0001047469-20-003964-index.htm
2020-07-09424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1744659/000104746920004044/0001047469-20-004044-index.htm
2020-09-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1744659/000108514620002410/0001085146-20-002410-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920002773/0001104659-20-002773-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920003136/0001104659-20-003136-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920003240/0001104659-20-003240-index.htm
2020-01-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920020276/0001104659-20-020276-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920021077/0001104659-20-021077-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920025042/0001104659-20-025042-index.htm
2020-03-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920033412/0001104659-20-033412-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920033680/0001104659-20-033680-index.htm
2020-03-16S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920034183/0001104659-20-034183-index.htm
2020-03-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920034208/0001104659-20-034208-index.htm
2020-03-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920040850/0001104659-20-040850-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920042006/0001104659-20-042006-index.htm
2020-04-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920051294/0001104659-20-051294-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920060866/0001104659-20-060866-index.htm
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920066655/0001104659-20-066655-index.htm
2020-06-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920068978/0001104659-20-068978-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920069071/0001104659-20-069071-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920069072/0001104659-20-069072-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920069074/0001104659-20-069074-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920069075/0001104659-20-069075-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920069077/0001104659-20-069077-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920071713/0001104659-20-071713-index.htm
2020-06-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920072520/0001104659-20-072520-index.htm
2020-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920072521/0001104659-20-072521-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920074004/0001104659-20-074004-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920078983/0001104659-20-078983-index.htm
2020-07-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1744659/000110465920079692/0001104659-20-079692-index.htm
2020-07-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1744659/000110465920080872/0001104659-20-080872-index.htm
2020-07-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1744659/000110465920080873/0001104659-20-080873-index.htm
2020-07-078-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920081704/0001104659-20-081704-index.htm
2020-07-07S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1744659/000110465920081820/0001104659-20-081820-index.htm
2020-07-104/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920082854/0001104659-20-082854-index.htm
2020-07-104/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920082855/0001104659-20-082855-index.htm
2020-07-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920083453/0001104659-20-083453-index.htm
2020-07-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000110465920083455/0001104659-20-083455-index.htm
2020-08-07RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920092022/0001104659-20-092022-index.htm
2020-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920093910/0001104659-20-093910-index.htm
2020-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1744659/000110465920115114/0001104659-20-115114-index.htm
2020-01-15SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1744659/000119312520008095/0001193125-20-008095-index.htm
2020-02-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1744659/000119312520028593/0001193125-20-028593-index.htm
2020-07-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1744659/000119312520192675/0001193125-20-192675-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000120919120008127/0001209191-20-008127-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1744659/000120919120054791/0001209191-20-054791-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1744659/000127417320000103/0001274173-20-000103-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1744659/000155837020002798/0001558370-20-002798-index.htm
2020-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1744659/000155837020006498/0001558370-20-006498-index.htm
2020-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1744659/000155837020010443/0001558370-20-010443-index.htm
2020-07-07EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1744659/999999999520001708/9999999995-20-001708-index.htm

Akero Therapeutics, Inc (AKRO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Akero Therapeutics, Inc (AKRO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 840%
Institutional Ownership: 9380%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-10-09Kevin BittermanDirectorSell13,000.0028.93376,090.0011,780.00https://www.sec.gov/Archives/edgar/data/1744659/000120919120054791/0001209191-20-054791-index.htm
2020-03-13Jonathan YoungChief Operating OfficerBuy5,035.000.623,096.53177,518.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920034208/0001104659-20-034208-index.htm
2020-03-13Jonathan YoungChief Operating OfficerBuy6,082.000.623,740.43183,600.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920034208/0001104659-20-034208-index.htm
2020-01-10Jonathan YoungChief Operating OfficerBuy17,621.000.6210,836.92211,197.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920003136/0001104659-20-003136-index.htm
2020-03-30G. Walmsley GrahamDirectorBuy2,168.0019.9743,294.962,168.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920042006/0001104659-20-042006-index.htm
2020-03-12Timothy RolphChief Scientific OfficerBuy27,368.000.6116,694.48220,277.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920033412/0001104659-20-033412-index.htm
2020-01-10Jonathan YoungChief Operating OfficerBuy21,286.000.6213,090.89232,483.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920003136/0001104659-20-003136-index.htm
2020-03-12Timothy RolphChief Scientific OfficerBuy22,656.000.6113,820.16242,933.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920033412/0001104659-20-033412-index.htm
2020-07-06Global Strategic Fund II L.P. venBio10% Share HolderSell4,603.0033.83155,721.333,033,552.00https://www.sec.gov/Archives/edgar/data/1744659/000090514820000773/0000905148-20-000773-index.htm
2020-07-02Global Strategic Fund II L.P. venBio10% Share HolderSell3,800.0033.63127,805.403,038,155.00https://www.sec.gov/Archives/edgar/data/1744659/000090514820000773/0000905148-20-000773-index.htm
2020-07-01Global Strategic Fund II L.P. venBio10% Share HolderSell108,064.0034.453,723,010.123,041,955.00https://www.sec.gov/Archives/edgar/data/1744659/000090514820000773/0000905148-20-000773-index.htm
2020-01-21Versant Venture Capital VI, L.P.10% Share HolderSell17,849.0022.39399,639.113,092,698.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-01-21Versant Venture Capital VI, L.P.10% Share HolderSell8,091.0021.78176,221.983,110,547.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-01-17Versant Venture Capital VI, L.P.10% Share HolderSell11,103.0020.09223,059.273,118,638.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-01-16Versant Venture Capital VI, L.P.10% Share HolderSell22,489.0019.72443,483.083,129,741.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920005671/0001104659-20-005671-index.htm
2020-03-06Global Strategic Fund II L.P. venBio10% Share HolderSell1,800.0023.7942,830.823,150,019.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000291/0001012975-20-000291-index.htm
2020-03-05Global Strategic Fund II L.P. venBio10% Share HolderSell8,500.0023.53200,010.953,151,819.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000291/0001012975-20-000291-index.htm
2020-01-15Versant Venture Capital VI, L.P.10% Share HolderSell7,511.0019.73148,192.033,152,230.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-01-14Versant Venture Capital VI, L.P.10% Share HolderSell12,307.0020.00246,140.003,159,741.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-03-04Global Strategic Fund II L.P. venBio10% Share HolderSell35,650.0023.81848,765.903,160,319.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000291/0001012975-20-000291-index.htm
2020-01-13Versant Venture Capital VI, L.P.10% Share HolderSell83.0020.841,729.723,172,048.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-01-13Versant Venture Capital VI, L.P.10% Share HolderSell11,593.0020.16233,714.883,172,131.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-01-10Versant Venture Capital VI, L.P.10% Share HolderSell19,343.0020.10388,794.303,183,724.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920004440/0001104659-20-004440-index.htm
2020-03-03Global Strategic Fund II L.P. venBio10% Share HolderSell6,401.0023.00147,198.683,195,969.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000275/0001012975-20-000275-index.htm
2020-03-02Global Strategic Fund II L.P. venBio10% Share HolderSell10,297.0023.06237,459.123,202,370.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000275/0001012975-20-000275-index.htm
2020-01-09Versant Venture Capital VI, L.P.10% Share HolderSell16,527.0020.21334,010.673,203,067.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920002773/0001104659-20-002773-index.htm
2020-02-28Global Strategic Fund II L.P. venBio10% Share HolderSell5,100.0021.30108,652.443,212,667.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000275/0001012975-20-000275-index.htm
2020-01-08Versant Venture Capital VI, L.P.10% Share HolderSell22,368.0019.80442,886.403,219,594.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920002773/0001104659-20-002773-index.htm
2020-02-10Global Strategic Fund II L.P. venBio10% Share HolderSell7,836.0027.08212,168.323,225,861.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000119/0001012975-20-000119-index.htm
2020-02-27Global Strategic Fund II L.P. venBio10% Share HolderSell1,781.0022.5440,143.743,227,767.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000267/0001012975-20-000267-index.htm
2020-02-26Global Strategic Fund II L.P. venBio10% Share HolderSell2,523.0022.4456,615.363,229,548.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000267/0001012975-20-000267-index.htm
2020-02-25Global Strategic Fund II L.P. venBio10% Share HolderSell1,600.0023.6737,876.003,232,071.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000267/0001012975-20-000267-index.htm
2020-02-12Global Strategic Fund II L.P. venBio10% Share HolderSell6.0027.14162.843,233,671.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000119/0001012975-20-000119-index.htm
2020-02-11Global Strategic Fund II L.P. venBio10% Share HolderSell2,184.0027.0559,068.033,233,677.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000119/0001012975-20-000119-index.htm
2020-02-06Global Strategic Fund II L.P. venBio10% Share HolderSell6,102.0027.03164,954.763,233,697.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000115/0001012975-20-000115-index.htm
2020-02-05Global Strategic Fund II L.P. venBio10% Share HolderSell28,608.0025.99743,547.673,239,799.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000113/0001012975-20-000113-index.htm
2020-01-07Versant Venture Capital VI, L.P.10% Share HolderSell14,162.0020.05283,948.103,241,962.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920002773/0001104659-20-002773-index.htm
2020-01-06Versant Venture Capital VI, L.P.10% Share HolderSell42,323.0019.93843,497.393,256,124.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-02-04Global Strategic Fund II L.P. venBio10% Share HolderSell53,731.0025.651,378,178.663,268,407.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000113/0001012975-20-000113-index.htm
2020-01-06Versant Venture Capital VI, L.P.10% Share HolderSell6,101.0018.32111,770.323,298,447.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-06Versant Venture Capital VI, L.P.10% Share HolderSell4,968.0017.6887,834.243,304,548.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-03Versant Venture Capital VI, L.P.10% Share HolderSell100.0020.272,027.003,309,516.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-03Versant Venture Capital VI, L.P.10% Share HolderSell3,100.0019.1859,458.003,309,616.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-13Global Strategic Fund II L.P. venBio10% Share HolderSell494,000.0020.239,993,620.003,322,138.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000033/0001012975-20-000033-index.htm
2020-01-08Global Strategic Fund II L.P. venBio10% Share HolderSell15,677.0019.86311,354.633,816,138.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000029/0001012975-20-000029-index.htm
2020-01-07Global Strategic Fund II L.P. venBio10% Share HolderSell31,000.0020.17625,149.103,831,815.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000022/0001012975-20-000022-index.htm
2020-01-06Global Strategic Fund II L.P. venBio10% Share HolderSell42,221.0019.64829,380.883,862,815.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000022/0001012975-20-000022-index.htm
2020-01-03Global Strategic Fund II L.P. venBio10% Share HolderSell12,498.0019.30241,213.903,905,036.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000013/0001012975-20-000013-index.htm
2020-01-02Global Strategic Fund II L.P. venBio10% Share HolderSell23,000.0019.94458,507.303,917,534.00https://www.sec.gov/Archives/edgar/data/1744659/000101297520000013/0001012975-20-000013-index.htm
2020-01-02Versant Venture Capital VI, L.P.10% Share HolderSell1,000.0022.1722,170.003,996,859.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-02Versant Venture Capital VI, L.P.10% Share HolderSell3,900.0021.2082,680.003,997,859.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-01-02Versant Venture Capital VI, L.P.10% Share HolderSell10,952.0019.89217,835.284,001,759.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920001732/0001104659-20-001732-index.htm
2020-07-10Apple Tree Partners IV, L.P.10% Share HolderBuy415,000.0036.0014,940,000.005,830,203.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920083455/0001104659-20-083455-index.htm
2020-07-10Seth Loring HarrisonDirectorBuy415,000.0036.0014,940,000.005,830,203.00https://www.sec.gov/Archives/edgar/data/1744659/000110465920083453/0001104659-20-083453-index.htm